drug launches

Supernus gears up for Q2 Qelbree launch, in time for back-to-school ADHD script season
Supernus gears up for Q2 Qelbree launch, in time for back-to-school ADHD script season
Fierce Pharma
Supernus Pharmaceuticals
Qelbree
ADHD
drug launches
Flag link:
3 Blockbuster Drug Launches to Watch This Year
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
Flag link:
Failure to launch? Half of drugs rolled out since 2004 didn't live up to sales forecasts: report
Failure to launch? Half of drugs rolled out since 2004 didn't live up to sales forecasts: report
Fierce Pharma
drug launches
Flag link:
Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients
Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients
Fierce Pharma
Horizon Pharma
thyroid eye disease
Tepezza
drug launches
DTC
Flag link:
Aducanumab tops 2021’s biggest potential launches
Aducanumab tops 2021’s biggest potential launches
EP Vantage
drug launches
Biogen
Eisai
aducanumab
efgartigimod
Argenx
Evrenzo
FibroGen
Astellas
AstraZeneca
Leqvio
Novartis
UCB Pharma
bimekizumab
Ascendis Pharma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
liso-cel
AXS-05
Axsome Therapeutics
voclosporin
Aurinia
Flag link:
JPM: Established relationships were key to pandemic drug launches, Incyte CEO says
JPM: Established relationships were key to pandemic drug launches, Incyte CEO says
Fierce Pharma
COVID-19
pandemic
drug launches
Incyte
JPMHC 2021
Flag link:
Agile Therapeutics' Q3 Focused on Launching Its New Contraceptive Patch
Agile Therapeutics' Q3 Focused on Launching Its New Contraceptive Patch
Motley Fool
Agile Therapeutics
drug launches
contraceptive patch
Twirla
Flag link:
Spectrum's Rolontis hits another setback as FDA faces COVID-19 plant inspection backlog
Spectrum's Rolontis hits another setback as FDA faces COVID-19 plant inspection backlog
Fierce Pharma
Spectrum Pharmaceuticals
neutropenia
Rolontis
drug launches
pandemic
COVID-19
Flag link:
Johnson & Johnson's immunology, cancer blockbusters deliver Q3 growth—and fuel hopes for 2021
Johnson & Johnson's immunology, cancer blockbusters deliver Q3 growth—and fuel hopes for 2021
Fierce Pharma
JNJ
earnings
drug launches
Flag link:
Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease
Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease
Yahoo/Reuters
Neurocrine Biosciences
drug launches
Parkinson's Disease
pandemic
COVID-19
Ogentys
Flag link:
Trevena preps low-key launch, responsible marketing for long-awaited opioid Olinvyk
Trevena preps low-key launch, responsible marketing for long-awaited opioid Olinvyk
Fierce Pharma
opioids
Trevena
Olinvyk
painkillers
drug launches
Flag link:
Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Fierce Pharma
Jazz Pharmaceuticals
solid tumors
cancer
Zepzelca
drug launches
Flag link:
Bristol Myers Squibb's Zeposia launches into crowded MS market
Bristol Myers Squibb's Zeposia launches into crowded MS market
Fierce Pharma
Bristol-Myers Squibb
Celgene
Zeposia
drug launches
MS
multiple sclerosis
Flag link:
BioCryst Plans to Raise $100 Million
BioCryst Plans to Raise $100 Million
Motley Fool
drug launches
Biocryst
HAE
berotralstat
Flag link:
Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
BioSpace
Neurocrine
drug launches
Ongentys
Parkinson's Disease
pandemic
COVID-19
Flag link:
Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Fierce Pharma
Immunomedics
drug launches
Trodelvy
triple-negative breast cancer
pandemic
COVID-19
Flag link:
Coronavirus puts on hold launch plans for Neurocrine's Parkinson's drug
Coronavirus puts on hold launch plans for Neurocrine's Parkinson's drug
Biopharma Dive
Neurocrine
Parkinson's Disease
drug launches
COVID-19
pandemic
Flag link:
Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal
Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal
Fierce Pharma
JNJ
vaccines
COVID-19
drug launches
CMOs
Emergent BioSolutions
Flag link:
Covid-19 adds a new danger to drug launches
Covid-19 adds a new danger to drug launches
EP Vantage
drug launches
pandemic
COVID-19
Esperion
Biohaven
Urogen
Flag link:
Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic
Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic
Marketwatch
COVID-19
pandemic
clinical trials
drug launches
M&A
conferences
Flag link:

Pages